Abstract
In recent years, constant increase in the performance of computer-based tools and several mathematical algorithms to solve chemistry-related problems. In recent years, screening of potent lead molecules using computational approaches has been gaining more attention as alternate approaches for high-throughput screening. Several cheminformatics tools are used in research, but integrating it with statistical methods are said to reflect the development of new algorithms and applications. These molecular modeling or cheminformatics methods strongly depend on the quantitative structure–activity relationship (QSAR) analysis. This QSAR technique is extensively applied to predict the pharmacokinetics property through the reference biological activity and it is one sound technique in the medicinal chemistry. Through this chapter, the basic principle of computational methods that relies on QSAR models, their descriptors, statistical phenomenon towards the molecular structures are discussed. At the same time, we also highlight the important components of QSAR models and their types to describe the molecular structure of lead molecules and discuss future limitations and perspectives to guide future research in the field of QSAR.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Acharya C, Coop A, Polli JE, Mackerell AD Jr (2011) Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach. Curr Comput Aided Drug Des 7:10–22
Afantitis A, Melagraki G, Sarimveis H, Koutentis PA, Markopoulos J, Igglessi-Markopoulou O (2006) A novel QSAR model for predicting induction of apoptosis by 4-aryl-4H-chromenes. Bioorg Med Chem 14:6686–6694
Akamatsu M (2002) Current state and perspectives of 3D QSAR. Curr Top Med Chem 2:1381–1394
Alam S, Khan F (2014) QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase II α. Drug Des Dev Ther 8:183–195
Allen BK, Mehta S, Ember SW, Schonbrunn E, Ayad N, Schürer SC (2015) Large-scale computational screening identifies first in class multitarget inhibitor of EGFR kinase and BRD4. Sci Rep 5:16924
Augen J (2002) The evolving role of information technology in the drug discovery process. Drug Discov Today 7:315–323
Bajorath J (2002) Integration of virtual and high-throughput screening. Nat Rev Drug Discov 1:882–894
Bajorath JR (ed) (2011) Chemoinformatics and computational chemical biology. Humana Press, Totowa
Balaban AT (1982) Highly discriminating distance-based topological index. Chem Phys Lett 89:399–404
Ban F, Dalal K, Li H, LeBlanc E, Rennie PS, Cherkasov A (2017) Best practices of computer-aided drug discovery: lessons learned from the development of a preclinical candidate for prostate cancer with a new mechanism of action. J Chem Inf Model 57:1018–1028
Baraldi PG (1999) Comparative molecular field analysis (CoMFA) of a series of selective adenosine receptor A2A antagonists. Drug Dev Res 46:126–133
Bauer MR, Ibrahim TM, Vogel SM, Boeckler FM (2013) Evaluation and optimization of virtual screening workflows with DEKOIS 2.0 – a public library of challenging docking benchmark sets. J Chem Inf Model 53:1447–1462
Bissantz C, Folkers G, Rognan D (2000) Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. J Med Chem 43:4759–4767
Bissantz C, Bernard P, Hibert M, Rognan D (2003) Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets? Proteins 50:5–25
Blum LC, Reymond JL (2009) 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13. J Am Chem Soc 131:8732–8733
Bolis G, Di Pace L, Fabrocini FJ (1991) A machine learning approach to computer-aided molecular design. Comput Aided Mol Des 5:617–628
Brignole EA, Bottini SB, Gani R (1986) A strategy for the solvents for liquid extraction of solvents for separation processes. Fluid Phase Equilib 29:125
Brozell SR, Mukherjee S, Balius TE, Roe DR, Case DA, Rizzo RC (2012) Evaluation of DOCK 6 as a pose generation and database enrichment tool. J Comput Aided Mol Des 26:749–773
Catalin B (2014) More effective DPP4 inhibitors as antidiabetics based on sitagliptin applied QSAR and clinical methods. Curr Comput Aided Drug Des 10:237–249(13)
Chang C, Swaan PW (2006) Computational approaches to modeling drug transporters. Eur J Pharm Sci 27:411–424
Cherkasov A, Muratov EN, Fourches D, Varnek A, Baskin II, Cronin M (2014) QSAR modeling: where have you been? Where are you going to? J Med Chem 57:4977–5010
Churchwell CJ, Rintoul MD, Martin S, Visco DP, Kotu A, Larson RS, Sillerud LO, Brown DC, Faulon J (2004) The signature molecular descriptor. 3. Inverse-quantitative structure-activity relationship of ICAM-1 inhibitory peptides. J Mol Graph Model 22:263–273
Clark DE, Pickett SD (2000) Computational methods for the prediction of ‘drug-likeness’. Drug Discov Today 5:49–58
Clark DE, Firth MA, Murray CW (1996) Molmaker: de novo generation of 3D databases for use in drug design. J Chem Inf Comput Sci 36:137
Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959–5967
Crivori P, Cruciani G, Carrupt PA, Testa B (2000) Predicting blood–brain barrier permeation from three-dimensional molecular structure. J Med Chem 43:2204–2216
Cruciani G, Crivori P, Carrupt PA, Testa B (2000) Molecular interaction fields in drug discovery: recent advances and future perspectives. J Mol Struct THEOCHEM 503:17–30
Crum-Brown AFT (1868) On the connection between chemical constitution and physiological action. Pt 1. On the physiological action of the salts of the ammonium bases, derived from strychnia, Brucia. Thebia, Codeia, Morphia and Nicotia. R Soc Edin 2:151–203
Cummings MD, DesJarlais RL, Gibbs AC, Mohan V, Jaeger EP (2005) Comparison of automated docking programs as virtual screening tools. J Med Chem 48:962–976
de Groot MJ, Ekins S (2002) Pharmacophore modeling of cytochromes P450. Adv Drug Deliv Rev 54:367–383
Dean PM (2005) Computer-aided design of small molecules for chemical genomics. Humana Press Inc., Totowa
Derringer GC, Markham RL (1985) A computer-based methodology for matching polymer structures with required properties. J Appl Polym Sci 30:4609–4617
Deshpande M, Kuramochi M, Karypis J (2002) Frequent substructure-based approaches for classifying chemical compounds. In: Proc of the 8th international conference on knowledge discovery and data mining, Edmonton
Dessalew N, Singh SK (2008) 3D-QSAR CoMFA and CoMSIA study on benzodipyrazoles as cyclin dependent kinase 2 inhibitors. Med Chem 4:313–321
Dessalew N, Bharatam PV, Singh SK (2007) 3D-QSAR CoMFA study on aminothiazole derivatives as cyclin-dependent kinase 2 inhibitors. QSAR Comb Sci 26:85–91
Diller DJ, Li R (2003) Kinases, homology models, and high throughput docking. J Med Chem 46:4638–4647
Douali L, Villemin D, Cherqaoui D (2003) Neural networks: accurate nonlinear QSAR model for HEPT derivatives. J Chem Inf Comput Sci 43:1200–1207
Ekins S, Lage de Siqueira-Neto J, McCall L-I, Sarker M, Yadav M, Ponder EL (2015) Machine learning models and pathway genome data base for Trypanosoma cruzi drug discovery. PLoS Negl Trop Dis 9:e0003878
Empereur-mot C, Guillemain H, Latouche A, Zagury JF, Viallon V, Montes M (2015) Predictiveness curves in virtual screening. J Chem Informatics 7:52
Eriksson L, Jaworska J, Worth AP, Cronin MT, McDowell RM, Gramatica P (2003) Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. Environ Health Perspect 111:1361–1375
Estrada E, Uriarte E (2001) Quantitative structure-toxicity relationships using TOPS-MODE. 1. Nitrobenzene toxicity to tetrahymena pyriformis. Environ Res 12:309–324
Faulon JL, Visco DP Jr, Pophale RS (2003) The signature molecular descriptor. 1. Using extended valence sequences in QSAR and QSPR studies. J Chem Inf Comput Sci 43:707–720
Fink T, Bruggesser H, Reymond JL (2005) Virtual exploration of the small-molecule chemical universe below 160 Daltons. Angew Chem Int Ed 44:1504–1508
Flower DR (2002a) Predicting chemical toxicity and fate. CRC Press, Roca Baton
Flower DR (2002b) Drug design: cutting edge approaches. Royal Society of Chemistry, Cambridge
Fourches D, Muratov E, Tropsha A (2015) Curation of chemogenomics data. Nat Chem Biol 11:535–535
Furnival GM, Wilson RW (1974) Regressions by leaps and bounds. Technometrics 16:499–511
Gao H, Williams C, Labute P, Bajorath J (1999) Binary Quantitative structure−activity relationship (QSAR) analysis of estrogen receptor ligands. J Chem Inf Comput Sci 39:164
Gasteiger J (2003) Handbook of chemoinformatics: from data to knowledge. Wiley, New York
Goh GB, Hodas NO, Vishnu A (2017) Deep learning for computational chemistry. J Comput Chem 38:1291–1307
Gohda K, Mori I, Ohta D, Kikuchi T (2000) A CoMFA analysis with conformational propensity: an attempt to analyze the SAR of a set of molecules with different conformational flexibility using a 3D-QSAR method. J Comput Aided Mol Des 14:265–275
Golbraikh A, Shen M, Xiao Z, Xiao YD, Lee KH, Tropsha A (2003) Rational selection of training and test sets for the development of validated QSAR models. J Comput Aided Mol Des 17:241–253
Gómez-Bombarelli R, Wei JN, Duvenaud D, Hernandez-Lobato JM, Sanchez-Lengeling B, Sheberla D, Aguilera-Iparraguirre J, Hirzel TD, Adams RP, Aspuru-Guzik A (2018) Automatic chemical design using a data-driven continuous representation of molecules. ACS Cent Sci 4:268–276
Good AC, Oprea TI (2008) Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection? J Comput Aided Mol Des 22:169–178
Guner OF (2002) History and evolution of the pharmacophore concept in computer-aided drug design. Curr Top Med Chem 2:1321–1332
Guyon I, Weston J, Barnhill S, Vapnik V (2002) Gene selection for cancer classification using support vector machines. Mach Learn 46:389
Hall LH, Kier LBJ (2000) Chem Inf Comput Sci 30:784–791
Hall DG, Manku S, Wang F (2001) Solution- and solid-phase strategies for the design, synthesis, and screening of libraries based on natural product templates: a comprehensive survey. J Comb Chem 3:125–150
Hammet LP (1935) Some relations between reaction rates and equilibrium constants. Chem Rev 17:125–136
Hasegawa K, Arakawab M, Funatsu K (2000) Rational choice of bioactive conformations through use of conformation analysis and 3-way partial least squares modeling. Chemom Intell Lab Syst 50:253–261
Hecht P (2002) High-throughput screening: beating the odds with informatics-driven chemistry. Curr Drug Discov 10:21–24
Helguera AM, Combes RD, Gonzalez MP, Cordeiro MN (2008) Applications of 2D descriptors in drug design: a DRAGON tale. Curr Top Med Chem 8:1628–1655
Hessler G, Zimmermann M, Matter H, Evers A, Naumann T, Lengauer T, Rarey M (2005) Multiple-ligand-based virtual screening: methods and applications of the MTree approach. J Med Chem 48:6575–6584
Huang N, Shoichet BK, Irwin JJ (2006) Benchmarking sets for molecular docking. J Med Chem 49:6789–6801
Ibrahim TM, Bauer MR, Boeckler FM (2015) Applying DEKOIS 2.0 in structure-based virtual screening to probe the impact of preparation procedures and score normalization. Aust J Chem 7:21
Irwin JJ (2008) Community benchmarks for virtual screening. J Comput Aided Mol Des 22:193–199
Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727–748
Kapetanovic IM (2008) Computer-aided drug discovery and development (CADDD): in-silico-chemico-biological approach. Chem Biol Interact 171:165–176
Kellenberger E, Rodrigo J, Muller P, Rognan D (2004) Comparative evaluation of eight docking tools for docking and virtual screening accuracy. Proteins 57:225–242
Kitchen DB, Decornez H, Furr JR, Bajorath J (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 3:935
Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130–4146
Koehn FE, Carter GT (2005) The evolving role of natural products in drug discovery. Nat Rev Drug Discov 2005:206–220
Kovatcheva A, Buchbauer G, Golbraikh A, Wolschann P (2003) QSAR modeling of alpha-campholenic derivatives with sandalwood odor. J Chem Inf Comput Sci 43:259–266
Kumar Singh S, Dessalew N, Bharatam PV (2007) 3D-QSAR CoMFA study on oxindole derivatives as cyclin dependent kinase 1 (CDK1) and cyclin dependent kinase 2 (CDK2) inhibitors. Med Chem 3:75–84
Kuntz ID, Blaney JM, Oatley SJ, Langridge R, Ferrin TE (1982) A geometric approach to macromolecule-ligand interactions. J Mol Biol 161:269–288
Labute PA (2000) Widely applicable set of descriptors. J Mol Graph Model 18:464–477
Lee KW, Briggs JM (2001) Comparative molecular field analysis (CoMFA) study of epothilones-tubulin depolymerization inhibitors: phramacophore developemt using 3D QSAR methods. J Comput Aided Mol Des 15:41–55
Lemmen C, Lengauer TJ (2000) Computational methods for the structural alignment of molecules. Comput Aided Mol Des 14:215–232
Lewis RA (2005) A general method for exploiting QSAR models in lead optimization. J Med Chem 48:1638–1648
Li P, Tian Y, Zhai H, Deng F, Xie M, Zhang X (2013) Study on the activity of non-purine xanthine oxidase inhibitor by 3D-QSAR modeling and molecular docking. J Mol Struct 5:56–65
Liu SS, Liu HL, Yin CS, Wang LSJ (2003) VSMP: a novel variable selection and modeling method based on the prediction. Chem Inf Comput Sci 43:964–969
MacKerell AD Jr (2004) Empirical force fields for biological macromolecules: overview and issues. J Comput Chem 25:1584–1604
Makino S, Ewing TJA, Kuntz ID (1999) DREAM++: flexible docking program for virtual combinatorial libraries. J Comput Aided Mol Des 13:513–532
Mandel J (1982) Use of the singular value decomposition in regression-analysis. Am Stat 36:15–24
Matter H, Baringhaus KH, Naumann T, Klabunde T, Pirard B (2001) Computational approaches towards the rational design of drug-like compound libraries. Comb Chem High Scr 4:453–475
McGovern SL, Shoichet BK (2003) Information decay in molecular docking screens against holo, apo, and modeled conformations of enzymes. J Med Chem 46:2895–2907
Mitchell JBO (2004) Machine learning methods in chemoinformatics. Wiley Interdiscip Rev Comput Mol Sci 4:468–481
Moustakas DT, Lang PT, Pegg S, Pettersen E, Kuntz ID, Brooijmans N, Rizzo RC (2006) Development and validation of a modular, extensible docking program: DOCK 5. J Comput Aided Mol Des 20:601–619
Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55(2012):6582–6594
Nantasenamat C, Monnor T, Worachartcheewan A, Mandi P, Isarankura-Na-Ayudhya C, Prachayasittikul V (2014) Predictive QSAR modeling of aldose reductase inhibitors using Monte Carlo feature selection. Eur J Med Chem 76:352–359
Netzeva TI, Gallegos SA, Worth AP (2006) Comparison of the applicability domain of a quantitative structure-activity relationship for estrogenicity with a large chemical inventory. Environ Toxicol Chem 25:1223–1230
Neves MA, Totrov M, Abagyan R (2012) Docking and scoring with ICM: the benchmarking results and strategies for improvement. J Comput Aided Mol Des 26:675–686
Nieto-Draghi C, Fayet G, Creton B, Rozanska X, Rotureau P, de Hemptinne JC, Ungerer P, Rousseau B, Adamo C (2015) A general guidebook for the theoretical prediction of physicochemical properties of chemicals for regulatory purposes. Chem Rev 115:13093–13164
Oprea TI, Davis AM, Teague SJ, Leeson PD (2001) Is there a difference between leads and drugs? A historical perspective. J Chem Inf Comput Sci 41:1308–1315
Panwar U, Singh SK (2020) Atom-based 3D-QSAR, molecular docking, DFT, and simulation studies of acylhydrazone, hydrazine, and diazene derivatives as IN-LEDGF/p75 inhibitors. Struct Chem 2020:1–16
Pastor M, Cruciani G, McLay I, Pickett S, Clementi S (2000) GRid-INdependent Descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. J Med Chem 43:3233–3243
Prado-Prado FJ, García I, García-Mera X, González-Díaz H (2011) Entropy multi-target QSAR model for prediction of antiviral drug complex networks. Chemom Intell Lab Syst 107:227–233
Prasanna S, Doerksen RJ (2009) Topological polar surface area: a useful descriptor in 2D-QSAR. Curr Med Chem 16:21–41
Pretel EJ, López PA, Bottini SB, Brignole EA (1994) Computer-aided molecular design of solvents for separation processes. AICHE J 40:1349–1360
Proudfoot JR (2002) Drugs, leads, and drug-likeness: an analysis of some recently launched drugs. Bioorg Med Chem Lett 12:1647–1650
Prusis P, Dambrova M, Andrianov V, Rozhkov E, Semenikhina V, Piskunova I, Ongwae E, Lundstedt T, Kalvinsh I, Wikberg JES (2004) Synthesis and quantitative structure−activity relationship of hydrazones of N-amino-N‘-hydroxyguanidine as electron acceptors for xanthine oxidase. J Med Chem 47:3105–3110
Rarey M, Kramer B, Lengauer T, Klebe G (1996) A fast flexible docking method using an incremental construction algorithm. J Mol Biol 261:470–489
Ravichandran V, Shalini S, Sundram KM, Dhanaraj SA (2010) QSAR study of substituted 1, 3, 4-oxadiazole naphthyridines as HIV-1 integrase inhibitors. Eur J Med Chem 45:2791–2797
Reddy AS, Pati SP, Kumar PP, Pradeep HN, Sastry GN (2007) Virtual screening in drug discovery - a computational perspective. Curr Protein Pept Sci 8:329–351
Reddy KK, Singh SK, Dessalew N, Tripathi SK, Selvaraj C (2012) Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors. J Enzyme Inhib Med Chem 27:339–347
Reddy KK, Singh SK, Tripathi SK, Selvaraj C (2013a) Identification of potential HIV-1 integrase strand transfer inhibitors: in silico virtual screening and QM/MM docking studies. SAR QSAR Environ Res 24:581–595
Reddy KK, Singh SK, Tripathi SK, Selvaraj C, Suryanarayanan V (2013b) Shape and pharmacophore-based virtual screening to identify potential cytochrome P450 sterol 14α-demethylase inhibitors. J Recept Signal Transduction 33:234–243
Repasky MP, Murphy RB, Banks JL, Greenwood JR, Tubert-Brohman I, Bhat S, Friesner RA (2012) Docking performance of the glide program as evaluated on the Astex and DUD datasets: a complete set of glide SP results and selected results for a new scoring function integrating WaterMap and glide. J Comput Aided Mol Des 26:787–799
Rester U (2006) Dock around the clock - current status of small molecule docking and scoring. QSAR Comb Sci 25:605–615
Roy K, Mitra I, Kar S, Ojha PK, Das RN, Kabir H (2012) Comparative studies on some metrics for external validation of QSAR model. J Chem Inf Model 52:396–408
Roy K, Kar S, Das RN (2015) Background of QSAR and historical developments. In: Das KRKN (ed) Understanding the basics of QSAR for applications in pharmaceutical sciences and risk assessment. Academic, Boston, pp 1–46
Ruddigkeit L, van Deursen R, Blum LC, Reymond JL (2012) Visualization and virtual screening of the chemical universe database GDB-17. J Chem Inf Model 52:2864
Ruggeri C, Drinkwater N, Sivaraman KK, Bamert RS, McGowan S, Paiardini A (2011) Identification and validation of a potent dual inhibitor of the P. falciparum M1 and M17 aminopeptidases using virtual screening. PLoS ONE 10:e0138957
Rusinko A III, Young SS, Drewry DH, Gerritz SW (2002) Optimization of focused chemical libraries using recursive partitioning. Comb Chem High Scr 5:125–133
Saliner AG, Netzeva TI, Worth AP (2006) Prediction of estrogenicity: validation of a classification model. Environ Res 17:195–223
Santos-Filho OA, Hopfinger AJ (2001) A search for sources of drug resistance by the 4D-QSAR analysis of a set of antimalarial dihydrofolate reductase inhibitors. J Comput Aided Mol Des 15:1–12
Schneider G, Baringhaus KH (2013) De novo design: from models to molecules. In: De novo molecular design. Wiley, Weinheim, pp 1–55
Schneider G, Fechner U (2005) Computer-based de novo design of drug-like molecules. Nat Rev Drug Discov 4:649
Selvaraj C, Singh P, Singh SK (2014) Molecular insights on analogs of HIV PR inhibitors toward HTLV‐1 PR through QM/MM interactions and molecular dynamics studies: comparative structure analysis of wild and mutant HTLV‐1 PR. J Mol Recognit 27:696–706
Sharma S, Ravichandran V, Jain PK, Mourya VK, Agrawal RK (2008) Prediction of caspase-3 inhibitory activity of 1,3-dioxo-4-methyl-2,3- dihydro-1h-pyrrolo[3,4-c] quinolines: QSAR study. J Enzyme Inhib Med Chem 23:424–431
Shen M, LeTiran A, Xiao Y, Golbraikh A, Kohn H, Tropsha A (2002) Quantitative structure-activity relationship analysis of functionalized amino acid anticonvulsant agents using k nearest neighbor and simulated annealing PLS methods. J Med Chem 45:2811–2823
Shen M, Xiao Y, Golbraikh A, Gombar VK, Tropsha A (2003) Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates. J Med Chem 46:3013–3020
Singh SK, Dessalew N, Bharatam PV (2006) 3D-QSAR CoMFA study on indenopyrazole derivatives as cyclin dependent kinase 4 (CDK4) and cyclin dependent kinase 2 (CDK2) inhibitors. Eur J Med Chem 41:1310–1319
Skvortsova MI, Fedyaev KS, Palyulin VA, Zefirov N (2001) Inverse structure-property relationship problem for the case of a correlation equation containing the Hosoya index. Dokl Chem 379:191–195
Southan C, Várkonyi P, Muresan S (2009) Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compounds. J Chem 1:10
Speck-Planche A, Cordeiro MNDS (2017) Fragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins. Mol Divers 21:511–523
Spitzer R, Jain AN (2012) Surflex-dock: docking benchmarks and real-world application. J Comput Aided Mol Des 26:687–699
Stanton DT, Egolf LM, Jurs PC, Hicks MG (1992) Computer assisted prediction of normal boiling points of pyrans and pyrroles. J Chem Inf Comput Sci 32:306–316
Stumpfe D, Bajorath J (2011) Applied virtual screening: strategies, recommendations, and caveats. In: Sotriffer C (ed) Virtual screening: principles, challenges, and practical guidelines. Wiley, Weinheim, pp 291–318
Suryanarayanan V, Kumar Singh S, Kumar Tripathi S, Selvaraj C, Konda Reddy K, Karthiga A (2013) A three-dimensional chemical phase pharmacophore mapping, QSAR modelling and electronic feature analysis of benzofuran salicylic acid derivatives as LYP inhibitors. Environ Res 24:1025–1040
Tang H, Yang L, Li J, Chen J (2016) Molecular modelling studies of 3,5- dipyridyl-1,2,4-triazole derivatives as xanthine oxidoreductase inhibitors using 3D-QSAR, TopomerCoMFA, molecular docking and molecular dynamic simulations. J Taiwan Inst Chem Eng 68:64–73
Tong W, Lowis DR, Perkins R, Chen Y, Welsh WJ, Goddette DW, Heritage TW, Sleehan DM (1998) Evaluation of quantitative structure-activity relationship methods for large-scale prediction of chemicals binding to the estrogen receptor. J Chem Inf Comput Sci 38:669
Tong W, Xie Q, Hong H, Shi L, Fang H, Perkins R (2004) Assessment of prediction confidence and domain extrapolation of two structure-activity relationship models for predicting estrogen receptor binding activity. Environ Health Perspect 112:1249–1254
Triballeau N, Acher F, Brabet I, Pin J-P, Bertrand H-O (2005) Virtual screening workflow development guided by the “receiver operating characteristic” curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J Med Chem 48:2534–2547
Tripos (2007) SYBYL8.0. In: Discovery software for computational chemistry and molecular modeling. St. Louis, Missouri, USA
Tropsha A (2010) Best practices for QSAR model development, validation, and exploitation. Mol Inform 29:476–488
Tropsha A, Gramatica P, Gombar VK (2003) The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. Quant Struct Act Relat Comb Sci 22:69–77
Van Drie JH (2003) Pharmacophore discovery: lessons learned. Curr Pharm Des 9:1649–1664
Varnek A, Baskin II (2011a) Chemoinformatics as a theoretical chemistry discipline. Mol Inf 30:20–32
Varnek A, Baskin II (2011b) Chemoinformatics as a theoretical chemistry discipline. Mol Informatics 30:20–32
Veerasamy R, Rajak H, Jain A, Sivadasan S, Varghese CP, Agrawal RK (2011) Validation of QSAR models - strategies and importance. Int J Drug Des Discov 2:511–519
Verdonk ML, Berdini V, Hartshorn MJ, Mooij WT, Murray CW, Taylor RD, Watson P (2004) Virtual screening using protein-ligand docking: avoiding artificial enrichment. J Chem Inf Comput Sci 44:793–806
Verma J, Khedkar VM, Coutinho EC (2010) 3D-QSAR in drug design- a review. Curr Top Med Chem 10:95–115
Vijaya Prabhu S, Singh SK (2018) Atom-based 3D-QSAR, induced fit docking, and molecular dynamics simulations study of thieno [2, 3-b] pyridines negative allosteric modulators of mGluR5. J Recept Signal Transduction 38:225–239
Vogel SM, Bauer MR, Boeckler FM (2011) DEKOIS: demanding evaluation kits for objective in silico screening—a versatile tool for benchmarking docking programs and scoring functions. J Chem Inf Model 51:2650–2665
Wedebye EB, Dybdahl M, Nikolov NG, Jonsdottir SO, Niemela JR (2015) QSAR screening of 70, 983 REACH substance for genotoxic carcinogenicity, mutagenicity and development toxicity in the Chem Screen project. Reprod Toxicol 55:64–72
Wegner JK, Frö hlich H, Zell AJ (2004) Feature selection for descriptor based classification models. 2. Human intestinal absorption (HIA). Chem Inf Comput Sci 44:921
Weis DC, Faulon JL, LeBorne RC, Visco DP (2005) The signature molecular descriptor. 5. The design of hydrofluoroether foam blowing agents using inverse-QSAR. Ind Eng Chem Res 44:8883–8891
Williams AJ, Ekins S (2011) A quality alert and call for improved curation of public chemistry databases. Drug Discov Today 16(2011):747–750
Xu J, Hagler A (2002) Chemoinformatics and drug discovery. Molecules 7:566–600
Xu J, Stevenson J (2000) Drug-like index: a new approach to measure drug-like compounds and their diversity. J Chem Inf Comput Sci 40:1177–1187
Xu L, Zhang WJ (2001) Comparison of different methods for variable selection. Anal Chim Acta 446:475–481
Xue L, Bajorath J (2000) Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening. Comb Chem 3:363–372
Yang SP, Song ST, Tang ZM, Song HF (2003) Optimization of antisense drug against conservative local motif in simulant secondary structures of HER-2 mRNA and QSAR analysis. Acta Pharmacol Sin 24:897–902
Yasuo K, Yamaotsu N, Gouda H, Tsujishita H, Hirono S (2009) Structure-based CoMFA as a predictive model - CYP2C9 inhibitors as a test case. J Chem Inf Model 49:853–864
Young D, Martin T, Venkatapathy R, Harten P (2008) Are the chemical structures in your QSAR correct? QSAR Comb Sci 27:1337–1345
Zhang S, Golbraikh A, Tropsha A (2006) Development of quantitative structure-binding affinity relationship models based on novel geometrical chemical descriptors of the protein-ligand interfaces. J Med Chem 49:2713–2724
Zhang S, Wei L, Bastow K, Zheng W, Brossi A, Lee KH, Tropsha A (2007) Antitumor Agents 252. Application of validated QSAR models to database mining: discovery of novel tylophorine derivatives as potential anticancer agents. J Comput Aided Mol Des 21:97–112
Acknowledgements
Vivek Srivastava thankfully acknowledge to Department of Biotechnology, Faculty of Engineering and Technology, Rama University Uttar Pradesh, Kanpur, India and also Chandrabose Selvaraj and Sanjeev Kumar Singh thankfully acknowledge to RUSA-Phase 2.0 Policy (TNmulti-Gen), Dept. of Edn, Govt. of India (Grant No: F.24-51/2014-U).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Srivastava, V., Selvaraj, C., Singh, S.K. (2021). Chemoinformatics and QSAR. In: Singh, V., Kumar, A. (eds) Advances in Bioinformatics. Springer, Singapore. https://doi.org/10.1007/978-981-33-6191-1_10
Download citation
DOI: https://doi.org/10.1007/978-981-33-6191-1_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-33-6190-4
Online ISBN: 978-981-33-6191-1
eBook Packages: Computer ScienceComputer Science (R0)